Cupric Ions Induce the Oxidation and Trigger the Aggregation of Human Superoxide Dismutase 1

PLoS ONE

Volumn 8, Issue 6, 2013, Pages

  Li, Cheng ^a   Xu, Wen Chang ^a   Xie, Zhen Sheng ^b   Pan, Kai ^a   Hu, Jiao ^a   Chen, Jie ^a   Pang, Dai Wen ^a   Yang, Fu Quan ^b   Liang, Yi ^a  

^a WUHAN UNIVERSITY   (China)

^b INSTITUTE OF BIOPHYSICS   (China)

Author keywords

[No Author keywords available]

Indexed keywords

COPPER ZINC SUPEROXIDE DISMUTASE; CUPRIC ION; CYSTEINE; HYDROGEN PEROXIDE; COPPER; DIVALENT CATION; PROTEIN AGGREGATE; RECOMBINANT PROTEIN; SOLUTION AND SOLUBILITY; SUPEROXIDE DISMUTASE;

ARTICLE; BINDING AFFINITY; BINDING SITE; CONTROLLED STUDY; ENZYME METABOLISM; MUTANT; OLIGOMERIZATION; PROTEIN AGGREGATION; WILD TYPE; AMINO ACID SEQUENCE; CHEMISTRY; ESCHERICHIA COLI; GENE EXPRESSION; GENETICS; HUMAN; KINETICS; METABOLISM; MOLECULAR GENETICS; MUTATION; OXIDATION REDUCTION REACTION; SOLUTION AND SOLUBILITY; THERMODYNAMICS;

AMINO ACID SEQUENCE; CATIONS, DIVALENT; COPPER; ESCHERICHIA COLI; GENE EXPRESSION; HUMANS; HYDROGEN PEROXIDE; KINETICS; MOLECULAR SEQUENCE DATA; MUTATION; OXIDATION-REDUCTION; PROTEIN AGGREGATES; RECOMBINANT PROTEINS; SOLUTIONS; SUPEROXIDE DISMUTASE; THERMODYNAMICS;

EID: 84878641566     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0065287     Document Type: Article

References (72)

1. Wijesekera LC, Leigh PN, (2009) Amyotrophic lateral sclerosis. Orphanet J Rare Dis 4: 3.
2. Valentine JS, Hart PJ, (2003) Misfolded CuZn SOD and amyotrophic lateral sclerosis. Proc Natl Acad Sci USA 100: 3617-3622.
3. Jiao M, Li HT, Chen J, Minton AP, Liang Y, (2010) Attractive protein-polymer interactions markedly alter the effect of macromolecular crowding on protein association equilibria. Biophys J 99: 914-923.
4. Rosen DR, Siddique T, Patterson D, Figlewicz DA, Sapp P, et al. (1993) Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature 362: 59-62.
5. Pasinelli P, Brown RH, (2006) Molecular biology of amyotrophic lateral sclerosis: insights from genetics. Nat Rev Neurosci 7: 710-723.
6. Wang Q, Johnson JL, Agar NYR, Agar JN, (2008) Protein aggregation and protein instability govern familial amyotrophic lateral sclerosis patient survival. PLoS Biol 6: e170.
7. Ip P, Mulligan VK, Chakrabartty A, (2011) ALS-causing SOD1 mutations promote production of copper-deficient misfolded species. J Mol Biol 409: 839-852.
8. Polymenidou M, Cleveland DW, (2011) The seeds of neurodegeneration: prion-like spreading in ALS. Cell 147: 498-508.
9. Nagano S (2012) Oxidative Modifications of Cu,Zn-Superoxide Dismutase (SOD1) - The Relevance to Amyotrophic Lateral Sclerosis (ALS), in: Amyotrophic Lateral Sclerosis, 301-312, InTech- Open Access Company, Rijeka, Croatia.
10. Que EL, Domaille DW, Chang CJ, (2008) Metals in neurobiology: probing their chemistry and biology with molecular imaging. Chem Rev 108: 1517-1549.
11. Desai V, Kaler SG, (2008) Role of copper in human neurological disorders. Am J Clin Nutr 88: 855S-858S.
12. Gaggelli E, Kozlowski H, Valensin D, Valensin G, (2006) Copper homeostasis and neurodegenerative disorders (Alzheimer's, prion, and Parkinson's diseases and amyotrophic lateral sclerosis). Chem Rev 106: 1995-2044.
13. Kepp KP, (2012) Bioinorganic chemistry of Alzheimer's disease. Chem Rev 112: 5193-5239.
14. Rae TD, Schmidt PJ, Pufahl RA, Culotta VC, O'Halloran TV, (1999) Undetectable intracellular free copper: the requirement of a copper chaperone for superoxide dismutase. Science. 284: 805-808.
15. Yim HS, Kang JH, Chock PB, Stadtman ER, Yim MB, (1997) A familial amyotrophic lateral sclerosis-associated A4V Cu, Zn-superoxide dismutase mutant has a lower Km for hydrogen peroxide. Correlation between clinical severity and the Km value. J Biol Chem 272: 8861-8863.
16. Kishigami H, Nagano S, Bush AI, Sakoda S, (2010) Monomerized Cu, Zn-superoxide dismutase induces oxidative stress through aberrant Cu binding. Free Radic Biol Med 48: 945-952.
17. Watanabe S, Nagano S, Duce J, Kiaei M, Li QX, et al. (2007) Increased affinity for copper mediated by cysteine 111 in forms of mutant superoxide dismutase 1 linked to amyotrophic lateral sclerosis. Free Radic Biol Med (42):: 1534-1542.
18. Bush AI, (2002) Is ALS caused by an altered oxidative activity of mutant superoxide dismutase? Nat Neurosci 5: 919-920.
19. Kiaei M, Bush AI, Morrison BM, Morrison JH, Cherny RA, et al. (2004) Genetically decreased spinal cord copper concentration prolongs life in a transgenic mouse model of amyotrophic lateral sclerosis. J Neurosci 24: 7945-7950.
20. Nagano S, Fujii Y, Yamamoto T, Taniyama M, Fukada K, et al. (2003) The efficacy of trientine or ascorbate alone compared to that of the combined treatment with these two agents in familial amyotrophic lateral sclerosis model mice. Exp Neurol 179: 176-180.
21. Tokuda E, Ono S, Ishige K, Watanabe S, Okawa E, et al. (2008) Ammonium tetrathiomolybdate delays onset, prolongs survival, and slows progression of disease in a mouse model for amyotrophic lateral sclerosis. Exp Neurol 13: 122-128.
22. Subramaniam JR, Lyons WE, Liu J, Bartnikas TB, Rothstein J, et al. (2002) Mutant SOD1 causes motor neuron disease independent of copper chaperone-mediated copper loading. Nat Neurosci 5: 301-307.
23. Wang J, Slunt H, Gonzales V, Fromholt D, Coonfield M, et al. (2003) Copper-binding-site-null SOD1 causes ALS in transgenic mice: aggregates of non-native SOD1 delineate a common feature. Hum Mol Genet 12: 2753-2764.
24. Prudencio M, Lelie H, Brown HH, Whitelegge JP, Valentine JS, et al. (2012) A novel variant of human superoxide dismutase 1 harboring amyotrophic lateral sclerosis-associated and experimental mutations in metal-binding residues and free cysteines lacks toxicity in vivo. J Neurochem 121: 475-485.
25. Bosco DA, Morfini G, Karabacak NM, Song Y, Gros-Louis F, et al. (2010) Wild-type and mutant SOD1 share an aberrant conformation and a common pathogenic pathway in ALS. Nat Neurosci 13: 1396-1403.
26. Barmada S, Finkbeiner S, (2010) Bringing SOD1 into the fold. Nat Neurosci 13: 1303-1304.
27. Stathopulos PB, Rumfeldt JA, Scholz GA, Irani RA, Frey HE, et al. (2003) Cu/Zn superoxide dismutase mutants associated with amyotrophic lateral sclerosis show enhanced formation of aggregates in vitro. Proc Natl Acad Sci USA 100: 7021-7026.
28. Fujiwara N, Nakano M, Kato S, Yoshihara D, Ookawara T, et al. (2007) Oxidative modification to cysteine sulfonic acid of Cys111 in human copper-zinc superoxide dismutase. J Biol Chem 282: 35933-35944.
29. Chattopadhyay M, Durazo A, Sohn SH, Strong CD, Gralla EB, et al. (2008) Initiation and elongation in fibrillation of ALS-linked superoxide dismutase. Proc Natl Acad Sci USA 105: 18663-18668.
30. Lyons TJ, Nersissian A, Goto JJ, Zhu H, Gralla EB, et al. (1998) Metal ion reconstitution studies of yeast copper-zinc superoxide dismutase: the "phantom" subunit and the possible role of Lys7p. J Biol Inorg Chem 3: 650-662.
31. Van den Berg B, Ellis RJ, Dobson CM, (1999) Effects of macromolecular crowding on protein folding and aggregation. EMBO J 18: 6927-6933.
32. Zhou BR, Liang Y, Du F, Zhou Z, Chen J, (2004) Mixed macromolecular crowding accelerates the oxidative refolding of reduced, denatured lysozyme: implications for protein folding in intracellular environments. J Biol Chem 279: 55109-55116.
33. Zhu HL, Meng SR, Fan JB, Chen J, Liang Y, (2011) Fibrillization of human Tau is accelerated by exposure to lead via interaction with His-330 and His-362. PLoS One 6: e25020.
34. Zhou Z, Fan JB, Zhu HL, Shewmaker F, Yan X, et al. (2009) Crowded cell-like environment accelerates the nucleation step of amyloidogenic protein misfolding. J Biol Chem 284: 30148-30158.
35. Zhu HL, Fernández C, Fan JB, Shewmaker F, Chen J, et al. (2010) Quantitative characterization of heparin binding to Tau protein. Implication for inducer-mediated Tau filament formation. J Biol Chem 285: 3592-3599.
36. Mo ZY, Zhu YZ, Zhu HL, Fan JB, Chen J, et al. (2009) Low micromolar zinc accelerates the fibrillization of human Tau via bridging of Cys-291 and Cys-322. J Biol Chem 284: 34648-34657.
37. Kong FL, Cheng W, Chen J, Liang Y, (2011) D-Ribose glycates β2-microglobulin to form aggregates with high cytotoxicity through a ROS-mediated pathway. Chem Biol Interact 194: 69-78.
38. Rakhit R, Cunningham P, Furtos-Matei A, Dahan S, Qi XF, et al. (2002) Oxidation-induced misfolding and aggregation of superoxide dismutase and its implications for amyotrophic lateral sclerosis. J Biol Chem 277: 47551-47556.
39. Zhou Z, Yan X, Pan K, Chen J, Xie ZS, et al. (2011) Fibril formation of the rabbit/human/bovine prion proteins. Biophys J 101: 1483-1492.
40. Yu J, Bippes CA, Hand GM, Muller DJ, Sosinsky GE, (2007) Aminosulfonate modulated pH-induced conformational changes in connexin26 hemichannels. J Biol Chem 282: 8895-8904.
41. Anderson M, Bocharova OV, Makarava N, Breydo L, Salnikov VV, et al. (2006) Polymorphism and ultrastructural organization of prion protein amyloid fibrils: an insight from high resolution atomic force microscopy. J Mol Biol 358: 580-596.
42. Frost B, Ollesch J, Wille H, Diamond MI, (2009) Conformational diversity of wild-type Tau fibrils specified by templated conformation change. J Biol Chem 284: 3546-3551.
43. Wegmann S, Jung YJ, Chinnathambi S, Mandelkow EM, Mandelkow E, et al. (2010) Human Tau isoforms assemble into ribbon-like fibrils that display polymorphic structure and stability. J Biol Chem 285: 27302-27313.
44. Liu H, Zhu H, Eggers DK, Nersissian AM, Faull KF, et al. (2000) Copper(2+) binding to the surface residue cysteine 111 of His46Arg human copper-zinc superoxide dismutase, a familial amyotrophic lateral sclerosis mutant. Biochemistry 39: 8125-8132.
45. Beus MD, Chung J, Colón W, (2004) Modification of cysteine 111 in Cu/Zn superoxide dismutase results in altered spectroscopic and biophysical properties. Protein Sci 13: 1347-1355.
46. Nordlund A, Leinartaite L, Saraboji K, Aisenbrey C, Gröbner G, et al. (2009) Functional features cause misfolding of the ALS-provoking enzyme SOD1. Proc Natl Acad Sci USA 106: 9667-9672.
47. Leinartaite L, Saraboji K, Nordlund A, Logan DT, Oliveberg M, (2010) Folding catalysis by transient coordination of Zn2+ to the Cu ligands of the ALS-associated enzyme Cu/Zn superoxide dismutase 1. J Am Chem Soc. 132: 13495-13504.
48. Potter SZ, Zhu H, Shaw BF, Rodriguez JA, Doucette PA, et al. (2007) Binding of a single zinc ion to one subunit of copper-zinc superoxide dismutase apoprotein substantially influences the structure and stability of the entire homodimeric protein. J Am Chem Soc. 129: 4575-4583.
49. Guareschi S, Cova E, Cereda C, Ceronic M, Donettid E, et al. (2012) An over-oxidized form of superoxide dismutase found in sporadic amyotrophic lateral sclerosis with bulbar onset shares a toxic mechanism with mutant SOD1. Proc Natl Acad Sci USA 109: 5074-5079.
50. Ray SS, Nowak RJ, Strokovich K, Brown RH Jr, Walz T, et al. (2004) An intersubunit disulfide bond prevents in vitro aggregation of a superoxide dismutase-1 mutant linked to familial amytrophic lateral sclerosis. Biochemistry 43: 4899-4905.
51. Doucette PA, Whitson LJ, Cao X, Schirf V, Demeler B, et al. (2004) Dissociation of human copper-zinc superoxide dismutase dimers using chaotrope and reductant. Insights into the molecular basis for dimer stability. J Biol Chem 279: 54558-54566.
52. Bounds PL, Sutter B, Koppenol WH, (2002) Studies of metal-binding properties of Cu,Zn superoxide dismutase by isothermal titration calorimetry. Methods Enzymol 349: 115-123.
53. Michel E, Nauser T, Sutter B, Bounds PL, Koppenol WH, (2005) Kinetics properties of Cu,Zn-superoxide dismutase as a function of metal content. Arch Biochem Biophys 439: 234-240.
54. Chao Y, Fu D, (2004) Thermodynamic studies of the mechanism of metal binding to the Escherichia coli zinc transporter YiiP. J Biol Chem 279: 17173-17180.
55. Wei Y, Fu D, (2005) Selective metal binding to a membrane-embedded aspartate in the Escherichia coli metal transporter YiiP (FieF). J Biol Chem 280: 33716-33724.
56. Ghai R, Falconer RJ, Collins BM, (2012) Applications of isothermal titration calorimetry in pure and applied research-survey of the literature from 2010. J Mol Recognit 25: 32-52.
57. Trumbull KA, Beckman JS, (2009) A role for copper in the toxicity of zinc-deficient superoxide dismutase to motor neurons in amyotrophic lateral sclerosis. Antioxid Redox Signal 11: 1627-1639.
58. Borchelt DR, Wong PC, Becher MW, Pardo CA, Lee MK, et al. (1998) Axonal transport of mutant superoxide dismutase 1 and focal axonal abnormalities in the proximal axons of transgenic mice. Neurobiol Dis 5: 27-35.
59. Rakhit R, Crow JP, Lepock JR, Kondejewski LH, Cashman NR, et al. (2004) Monomeric Cu,Zn-superoxide dismutase is a common misfolding intermediate in the oxidation models of sporadic and familial amyotrophic lateral sclerosis. J Biol Chem 279: 15499-15504.
60. Hwang YW, Stathopulos PB, Dimmick K, Yang H, Badiei HR, et al. (2010) Nonamyloid aggregates arising from mature copper/zinc superoxide dismutases resemble those observed in amyotrophic lateral sclerosis. J Biol Chem 285: 41701-41711.
61. Kerman A, Liu HN, Croul S, Bilbao J, Rogaeva E, et al. (2010) Amyotrophic lateral sclerosis is a non-amyloid disease in which extensive misfolding of SOD1 is unique to the familial form. Acta Neuropathol 119: 335-344.
62. Rakhit R, Robertson J, Vande Velde C, Horne P, Ruth DM, et al. (2007) An immunological epitope selective for pathological monomer-misfolded SOD1 in ALS. Nat Med 13: 754-759.
63. Chattopadhyay M, Valentine JS, (2009) Aggregation of copper-zinc superoxide dismutase in familial and sporadic ALS. Antioxid Redox Signal 11: 1603-1614.
64. Ezzi SA, Urushitani M, Julien JP, (2007) Wild-type superoxide dismutase acquires binding and toxic properties of ALS-linked mutant forms through oxidation. J Neurochem 102: 170-178.
65. Brotherton TE, Li Y, Cooper D, Gearing M, Julien JP, et al. (2012) Localization of a toxic form of superoxide dismutase 1 protein to pathologically affected tissues in familial ALS. Proc Natl Acad Sci USA 109: 5505-5510.
66. Son M, Puttaparthi K, Kawamata H, Rajendran B, Boyer PJ, et al. (2007) Overexpression of CCS in G93A-SOD1 mice leads to accelerated neurological deficits with severe mitochondrial pathology. Proc Natl Acad Sci USA 104: 6072-6077.
67. Kim HK, Chung YW, Chock PB, Yim MB, (2011) Effect of CCS on the accumulation of FALS SOD1 mutant-containing aggregates and on mitochondrial translocation of SOD1 mutants: implication of a free radical hypothesis. Arch Biochem Biophys 509: 177-185.
68. Chang Y, Kong Q, Shan X, Tian G, Ilieva H, et al. (2008) Messenger RNA oxidation occurs early in disease pathogenesis and promotes motor neuron degeneration in ALS. PLoS One 3: e2849.
69. Beckman JS, Esétvez AG, Barbeito L, Crow JP, (2002) CCS knockout mice establish an alternative source of copper for SOD in ALS. Free Radic Biol Med 10: 1433-1435.
70. Colombo MF, Austrilino L, Nascimento OR, Castellano EE, Tabak M, (1987) On the interaction of copper with tris(hydroxymethyl)aminomethane. Can J Chem 65: 821-826.
71. Tokuda E, Okawa E, Ono S, (2009) Dysregulation of intracellular copper trafficking pathway in a mouse model of mutant copper/zinc superoxide dismutase-linked familial amyotrophic lateral sclerosis. J Neurochem 111: 181-191.
72. Chen X, Shang H, Qiu X, Fujiwara N, Cui L, et al. (2012) Oxidative modification of cysteine 111 promotes disulfide bond-independent aggregation of SOD1. Neurochem Res 37: 835-845.